+Search query
-Structure paper
Title | Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer. |
---|---|
Journal, issue, pages | J. Biomed. Sci., Vol. 29, Page 29-29, Year 2022 |
Publish date | May 4, 2021 (structure data deposition date) |
Authors | Liu, J.S. / Fang, W.K. / Yang, S.M. / Wu, M.C. / Chen, T.J. / Chen, C.M. / Lin, T.Y. / Liu, K.L. / Wu, C.M. / Chen, Y.C. ...Liu, J.S. / Fang, W.K. / Yang, S.M. / Wu, M.C. / Chen, T.J. / Chen, C.M. / Lin, T.Y. / Liu, K.L. / Wu, C.M. / Chen, Y.C. / Chuu, C.P. / Wang, L.Y. / Hsieh, H.P. / Kung, H.J. / Wang, W.C. |
External links | J. Biomed. Sci. / PubMed:35534851 |
Methods | X-ray diffraction |
Resolution | 2.6 Å |
Structure data | PDB-7eqv: |
Chemicals | ChemComp-DHB: ChemComp-NI: ChemComp-ZN: ChemComp-CL: ChemComp-HOH: |
Source |
|
Keywords | OXIDOREDUCTASE / Human histone lysine demethylase 4A / Lysine-specific demethylase 4A / KDM4A / JMJD2A / 3 / 4-dihydroxybenzoic acid / Inhibitor |